Patents by Inventor Julia FOSTER

Julia FOSTER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230399337
    Abstract: Pharmaceutical compositions of the invention comprise kinase inhibitors having a disease-modifying action in the treatment of diseases associated with BCR-ABL activity that include cancer, including chronic myeloid leukemia, acute lymphoblastic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, multiple myeloma, lymphomas, and metastatic carcinoma.
    Type: Application
    Filed: May 31, 2023
    Publication date: December 14, 2023
    Inventors: Ayyappan RAJASEKARAN, Jon SWANSON, Peter KANE, Julia FOSTER
  • Patent number: 11697654
    Abstract: Pharmaceutical compositions of the invention comprise kinase inhibitors having a disease-modifying action in the treatment of diseases associated with BCR-ABL activity that include cancer, including chronic myeloid leukemia, acute lymphoblastic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, multiple myeloma, lymphomas, and metastatic carcinoma.
    Type: Grant
    Filed: March 18, 2019
    Date of Patent: July 11, 2023
    Assignee: ALLCRON PHARMA INC.
    Inventors: Ayyappan Rajasekaran, Jon Swanson, Peter Kane, Julia Foster
  • Publication number: 20210040104
    Abstract: Pharmaceutical compositions of the invention comprise kinase inhibitors having a disease-modifying action in the treatment of diseases associated with BCR-ABL activity that include cancer, including chronic myeloid leukemia, acute lymphoblastic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, multiple myeloma, lymphomas, and metastatic carcinoma.
    Type: Application
    Filed: March 18, 2019
    Publication date: February 11, 2021
    Inventors: Ayyappan RAJASEKARAN, Jon SWANSON, Peter KANE, Julia FOSTER